Small Animal Imaging Market has dynamic and ever-changing trends, which reflect the increasing importance of preclinical research in pharmaceutical and biotechnology industries. The market mainly comprises advanced imaging modalities designed for studying small animals like mice and rats to understand disease mechanisms, drug efficacy, and treatment response. Market dynamics of small animal imaging are changing drastically as the need for accurate and non-invasive imaging tools continues to increase in preclinical studies.
One of the key drivers of this market is personalized medicine and better understanding of diseases at molecular levels. Small animal imaging is essential in this regard as it allows researchers to see into living things’ cells and molecules so that they can study molecular processes in them. Molecular imaging technologies such as positron emission tomography (PET), single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) have been developed specifically for use with small animals.
Also, growth in chronic diseases cases coupled with increased concerns regarding their treatments necessitate further investments towards research and development activities thereby pushing forward the small animal imaging market. Pharmaceutical companies and research institutions now rely more on preclinical studies to support their drug candidates, screen their safety profiles, predict any possible side effects before proceeding into clinical trials. This trend has led to an increase in adoption of small animal imaging technologies resulting in a vibrant market ecosystem.
Technological advancement has played a major role shaping market dynamics recently. These developments include advancements such as high resolution imaging, multimodal image platforms as well as integration of artificial intelligence into image analysis have significantly improved small animal imaging systems capabilities. Besides providing more precise data with greater detailing these improvements streamline the process by which images are taken hence reducing timeframes or resources required during preclinical studies.
Another common approach among industry players today involves forming collaborations or partnerships to foster innovation while meeting different researcher requirements. These firms aim at providing complete solutions that satisfy various research community needs since they bring together experience from separate domains like imaging technology, software development and data analytics. The pace of technological advancement has therefore increased through this collaborative approach while the small animal imaging market expanded globally.
Nevertheless, there are obstacles to growth of the market including high equipment costs and ethical concerns around use of animals in research. These challenges are being addressed through the provision of cheaper imaging options and promotion of ethics in preclinical research. As regulatory scrutiny increases stakeholders within the industry are actively seeking to align small animal imaging practices with ethical standards and promote responsible use of animals for research purposes.”
Small Animal Imaging Market Overview
The Small Animal Imaging Market size is expected to reach USD 14.9 Billion by 2032 at 6.2% CAGR during the forecast period 2023-2032. Small animal imaging is a technique that uses imaging equipment and reagents to monitor molecular or cellular processes in animals such as rats and mice for drug development and gene expression research.
However, regulatory rules governing the use of animals in investigations, as well as the expensive cost of equipment, may limit the expansion of the small animal imaging industry. The growing need for non-invasive small animal imaging techniques, as well as technical breakthroughs in the sector, is propelling the market forward. Furthermore, major market players are concentrating on launching new products on a regular basis, which is expected to contribute to market growth.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VP, CEO's, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the small animal imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
Segmentation
The small animal imaging market is segmented on the basis of the modality and reagents.
On the basis of the modality, the market is classified into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, photoacoustic imaging systems, and Magnetic Particle Imaging (MPI) systems. The optical imaging systems are further segmented into bioluminescence/ fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-Ray/optical + CT systems. The nuclear imaging systems are segmented into micro-Pet systems, micro-spect systems, and trimodality (spect/pet/CT) systems. The micro-pet system is further segmented into standalone pet systems, pet/CT system, and pet/MRI systems. The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.
On the basis of reagent, the market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents are further segmented as bioluminescent imaging reagents and fluorescent imaging reagents. The bioluminescent imaging reagents are further segmented into luciferins, pro-luciferins, coelenterazine, and other bioluminescent imaging reagents. The fluorescent imaging reagents are further segmented as green fluorescent proteins, red fluorescent proteins, infrared dyes, other fluorescent imaging reagents. The nuclear imaging reagents are segmented into pet tracers and spect probes. The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes. The spect probes are further segmented into technetium-99m-based small animal spect probes, iodine-131-based small animal spect probes, gallium-67-based small animal spect probes, thallium-201-based small animal spect probes, and other spect probes. The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas small animal imaging market is further segmented into North America, and South America. North America is further classified as U.S. and Canada.
The Europe small animal imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific small animal imaging market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle East & Africa small animal imaging market is segmented into the Middle East and Africa.
Regional Market Summary
The Americas is likely to dominate the global small animal imaging market owing to investments by clinical research organizations in pre-clinical studies, increasing government funding in research activities and increasing number of pharmaceutical and research-based organizations. For instance, the National Institute of Health (NIH) received 1 Billion USD, in the year 2015 for life science and health-related research and development programs. Moreover, the presence of leading market players such as PerkinElmer Inc., Bruker Corporation, Trifoil Imaging, and LI-COR Biosciences within the region contributes to the market growth.
Europe is expected to hold the second position in the global small animal imaging market. The market growth is attributed to rising R&D investments by pharmaceutical companies and growing number of research organizations for diagnosis of diseases. For instance, the European Commission stated that the R&D spending by pharmaceuticals and biotechnology sector grew by 8.7% in 2021.
The Asia Pacific is the fastest growing region in global small animal imaging market. The developing countries such as China and India are offering high growth opportunities for the small animal imaging market players. Moreover, increasing government support for biotechnology and pharmaceutical R&D and growing number of translational research activities contributes to the market growth.
The Middle East & Africa holds the lowest share of the global small animal imaging market due to low development in the healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global small animal imaging market are PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany).
Small Animal Imaging Market, by Modality
Small Animal Imaging Market, by Reagents
Small Animal Imaging Market, by Region
Company Profiles
Recent Development
PerkinElmer, Inc., formerly Perkin-Elmer, is an American multinational organization that specializes in diagnostics, life science research, food, environmental, and industrial testing. For a variety of end markets, PerkinElmer manufactures analytical equipment, genetic testing, and diagnostic tools, medical imaging components, software, devices, and consumables. PerkinElmer is an S & P 500 company with operations in 190 countries.
Molecular biology, chemistry, computer science, engineering, and medicine are all involved in molecular imaging. Optical imaging (either by bioluminescence or fluorescence), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and ultrasound have all been used to monitor structural, functional, and molecular changes in cancer tissues (US). In 2021, the company said, the worldwide molecular imaging market is predicted to be worth the US $4,309.0 million, growing at a CAGR of 5.4 percent over the forecast period (2021–2028).Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)